AMIA’s goal is to improve the legislative and regulatory environment for health informatics research, practice and education through AMIA member expertise. The primary pathway through which AMIA achieves this goal is by engaging Federal Agencies and Congress on public calls for input, such as Notices of Proposed Rulemakings (NPRMs) or Request for Information (RFIs).
Learn more about the comment process
AMIA responses are arranged by Federal Agency and Congressional Committee.
In conjunction with a public meeting held by the FDA August 15, 2016, AMIA submitted public comments supporting the direction of the its Prescription Drug User Fee Agreement Commitment Letter. Specifically, AMIA supports FDA’s work to utilize Real World Evidence in regulatory decision-making, incorporating the patient’s voice in drug development […]
On July 18, 2016, AMIA submitted comments to FDA regarding their draft guidance to industry on using EHR data in clinical investigations. AMIA was supportive of the guidance, but challenged the assertion that EHR data was readily usable for prospective randomized controlled trials.
On June 27, 2016 AMIA submitted comments to CMS regarding proposed policies related to the new Medicare Quality Payments Program, which replaces the Sustainable Growth Rate and reforms how nearly 1.3 million clinicians are paid through Medicare. AMIA described a set of principles and recommendations CMS should consider during implementation […]
On May 23, 2016, AMIA submitted comments to the Office of the National Coordinator recommending they develop a patient-centric approach to measuring nationwide health IT interoperability. As part of this recommendation, AMIA described a new methodology and approach to measuring interoperability that they said should be developed immediately. AMIA also […]
On April 27, 2016, AMIA submitted comments to the Office of the National Coordinator supporting their proposed authority to conduct direct review of certified health IT products. AMIA said that reviews should be limited to instances when health IT posed a potential or real threat to patient safety, or was […]
On April 6, 2016, AMIA called proposed revisions to substance use disorder (SUD) regulations, also known as 42 CFR Part 2, well-intentioned, but ultimately insufficient. AMIA urged the Department of Health and Human Services (HHS) to lead a national effort to develop technical standards that would enable patients to have […]
On January 26, 2016, AMIA submitted a letter of support for the Office of the National Coordinator for Health Information Technology (ONC) “Private Sector Interoperability Commitments Pledge,” which seeks to bolster interoperability in healthcare by enabling consumer access to their data, improving transparency and encouraging widespread adoption of […]
The following statement was released today by Douglas B. Fridsma, M.D., PhD., FACP, FACMI, President and CEO, American Medical Informatics Association (AMIA).
AMIA appreciates the work and bipartisanship demonstrated by Chairman Alexander, Ranking Member Murray and the entire HELP Committee in crafting the Improving Health Information Technology Act of 2015 […]
On February 1, 2016, AMIA submitted comments to the Centers for Medicare and Medicaid Services making several recommendations of how to improve quality measurement in an electronic environment. The group called for an overhaul to the current process, while looking to specialty societies for expert prioritization.
On January 11, 2016, AMIA submitted comments to the National Qualify Forum’s Health IT Safety Committee, supporting the framework and newly-developed domains to measure the safety and safe use of health IT. Numerous AMIA members participated in this effort, and AMIA believes these measures should serve as a foundation for […]